newsfilter
← Latest News
PR Newswire·

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX

  • Ardelyx Chief Commercial Officer Eric Foster is named as an individual defendant in a securities class action alleging he misled investors about the effectiveness of the company's patient-access strategy.
  • The lawsuit claims Foster assured investors that prior authorization & step edit requirements were not restricting prescriptions for IBSRELA & XPHOZAH while these barriers were allegedly slowing new-patient starts.
  • Investors who purchased Ardelyx securities between January 13, 2025, & August 6, 2026, are the potential class members.
  • The lead plaintiff application deadline is set for November 16, 2026.
  • Ardelyx stock fell approximately 18% to $4.00 on August 7, 2026, following an 18% decline after the company reduced its 2026 IBSRELA revenue guidance & withdrew long-term XPHOZAH guidance due to increased payer utilization-management processes.
  • Foster allegedly oversaw commercial strategies for IBSRELA ($158.3 million in 2024 U.S. sales) & XPHOZAH ($160.9 million in its first full year), including a 2025 field access team expansion & a February 2025 directive telling physicians to prescribe based on patient need while Ardelyx handled access adjudication.
  • The complaint alleges Foster made false representations that prior authorization approval rates were "very high" & patient access was "flowing through in 2025" while omitting facts about more stringent access requirements.
  • Claims are brought under Section 10(b) & Rule 10b-5, with Section 20(a) control person liability asserted against Foster for his authority over press releases & investor presentations.
  • The case is filed by SueWallSt, powered by Levi & Korsinsky LLP, which represents aggrieved shareholders in complex securities litigation.
  • Eligible investors do not need to take immediate action to remain class members, though those seeking to serve as lead plaintiffs must apply by the November 16, 2026 deadline.